Research map: Gut microbiome dysbiosis, short-chain fatty acid depletion and implications for neuroinflammation in atypical parkinsonian syndromes – a systematic review of patient cohorts

Back to the article

Papers in this map

  1. QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies · Penny F. Whiting · 2011 · 14558 citations · Cited by this paper
  2. Integrating a biopsychosocial perspective: WHODAS 2.0 enhances functioning assessment in Parkinson's disease · 2026 · Related
  3. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic · Colin Hill · 2014 · 9544 citations · Cited by this paper
  4. A case of monotherapy with intracerebroventricular anaerobic dopamine allows complete control of Parkinson's disease symptoms · 2025 · Related
  5. Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes · Gary D. Wu · 2011 · 6716 citations · Cited by this paper
  6. A review of FDG-PET biomarker analysis methods in Parkinson's disease · 2026 · Related
  7. Revised Estimates for the Number of Human and Bacteria Cells in the Body · Ron Sender · 2016 · 5280 citations · Cited by this paper
  8. Effects of deep brain stimulation on functional autonomy and quality of life in Parkinson's disease: A systematic review and meta-analysis · 2026 · Related
  9. Lipopolysaccharide Endotoxins · Christian R.H. Raetz · 2002 · 4436 citations · Cited by this paper
  10. Association between age at Parkinson's disease onset and divorce: An exploratory analysis from the fox insight cohort · 2026 · Related
  11. Gut Microbiota in Health and Disease · Inna Sekirov · 2010 · 4218 citations · Cited by this paper
  12. Continuous apomorphine infusion modulates cortical hyperexcitability and abnormal plasticity in Parkinson's disease · 2026 · Related
  13. Formation of propionate and butyrate by the human colonic microbiota · Petra Louis · 2016 · 3074 citations · Cited by this paper
  14. Rethinking the concept of disease modification in an evolving Parkinson's disease treatment landscape · 2026 · Related
  15. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria · Günter U. Höglinger · 2017 · 2434 citations · Cited by this paper
  16. Cognition endpoints for Parkinson's disease: A roadmap for developing patient-focused assessment tools to accelerate drug development · 2026 · Related
  17. Microbiome definition re-visited: old concepts and new challenges · Gabriele Berg · 2020 · 2287 citations · Cited by this paper
  18. Aligning incentives for open science in biomedical research: Navigating funder and institutional perspectives · 2025 · Related
  19. Molecular Analysis of Commensal Host-Microbial Relationships in the Intestine · Lora V. Hooper · 2001 · 2234 citations · Cited by this paper
  20. Prevalence and related factors of blood pressure regulation abnormalities in Parkinson's disease: Orthostatic hypotension and supine hypertension · 2025 · Related
  21. The Microbiome and Butyrate Regulate Energy Metabolism and Autophagy in the Mammalian Colon · Dallas R. Donohoe · 2011 · 2016 citations · Cited by this paper
  22. Criteria for the diagnosis of corticobasal degeneration · Melissa J. Armstrong · 2013 · 1964 citations · Cited by this paper
  23. Interactions between commensal intestinal bacteria and the immune system · Andrew J. Macpherson · 2004 · 1619 citations · Cited by this paper
  24. The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host–microbial interactions · Malin Johansson · 2010 · 1474 citations · Cited by this paper
  25. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome · Laurence Macia · 2015 · 1470 citations · Cited by this paper
  26. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. · William E.W. Roediger · 1980 · 1336 citations · Cited by this paper
  27. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome) · Mátyás I. Papp · 1989 · 1006 citations · Cited by this paper
  28. Multiple system atrophy: A review of 203 pathologically proven cases · Gregor Karl Wenning · 1997 · 805 citations · Cited by this paper
  29. Impact of commonly used drugs on the composition and metabolic function of the gut microbiota · Arnau Vich Vila · 2020 · 801 citations · Cited by this paper
  30. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy · PSP Genetics Study Group · 2011 · 640 citations · Cited by this paper
  31. The natural history of multiple system atrophy: a prospective European cohort study · Gregor Karl Wenning · 2013 · 549 citations · Cited by this paper
  32. Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism · Michela Barichella · 2018 · 404 citations · Cited by this paper
  33. Characterizing the mucin-degrading capacity of the human gut microbiota · Janiece S. Glover · 2022 · 323 citations · Cited by this paper
  34. Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic · Rubhana Raqib · 2006 · 318 citations · Cited by this paper
  35. Physiological Modulation of Intestinal Motility by Enteric Dopaminergic Neurons and the D 2 Receptor: Analysis of Dopamine Receptor Expression, Location, Development, and Function in Wild-Type and Knock-Out Mice · Zhi Shan Li · 2006 · 278 citations · Cited by this paper
  36. The development methods of official GRADE articles and requirements for claiming the use of GRADE – A statement by the GRADE guidance group · Holger Jens Schünemann · 2023 · 275 citations · Cited by this paper
  37. Presentation, diagnosis, and management of multiple system atrophy in Europe: Final analysis of the European multiple system atrophy registry · Martin Köllensperger · 2010 · 262 citations · Cited by this paper
  38. The role of Akkermansia muciniphila in inflammatory bowel disease: Current knowledge and perspectives · Mengyu Zheng · 2023 · 235 citations · Cited by this paper
  39. Large-scale benchmarking reveals false discoveries and count transformation sensitivity in 16S rRNA gene amplicon data analysis methods used in microbiome studies · Jonathan Thorsen · 2016 · 227 citations · Cited by this paper

Source: OpenAlex (CC0)